A clinical trial comparing two different clot-dissolving medications in ischemic stroke patients planned for endovascular stroke treatment. EXTEND-IA TNK randomizes patients to alteplase 0.9mg/kg versus tenecteplase 0.25mg/kg The primary outcome is the rate of reperfusion prior to endovascular treatment.
- Heart Foundation
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.